{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:40:07Z","timestamp":1790980807593,"version":"4.1.0"},"reference-count":46,"publisher":"BMJ","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:sec>\n                  <jats:title>Background and aims:<\/jats:title>\n                  <jats:p>Activated hepatic stellate cells (HSCs) but not quiescent HSCs express cyclo-oxygenase-2 (COX-2), suggesting that the COX-2\/prostanoid pathway has an active role in hepatic fibrogenesis. However, the role of COX-2 inhibitors in hepatic fibrogenesis remains controversial. The aim of this study was to investigate the antifibrotic effects of celecoxib, a selective COX-2 inhibitor.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>The effects of various COX inhibitors\u2014that is, ibuprofen, celecoxib, NS-398 and DFU, were investigated in activated human HSCs. Then, the antifibrotic effect of celecoxib was evaluated in hepatic fibrosis developed by bile duct ligation (BDL) or peritoneal thioacetamide (TAA) injection in rats.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Celecoxib, NS-398 and DFU inhibited platelet-derived growth facor (PDGF)-induced HSC proliferation; however, only celecoxib (\u2a7e50 \u03bcM) induced HSC apoptosis. All COX inhibitors completely inhibited prostaglandin E<jats:sub>2<\/jats:sub> (PGE<jats:sub>2<\/jats:sub>) and PGI<jats:sub>2<\/jats:sub> production in HSCs. Separately, PGE<jats:sub>2<\/jats:sub> and PGI<jats:sub>2<\/jats:sub> induced cell proliferation and extracellular signal-regulated kinase (ERK) activation in HSCs. All COX inhibitors attenuated ERK activation, but only celecoxib significantly inhibited Akt activation in HSCs. Celecoxib-induced apoptosis was significantly attenuated in HSCs infected with adenovirus containing a constitutive active form of Akt (Ad5myrAkt). Celecoxib had no significant effect on PPAR\u03b3 (peroxisome proliferator-activated receptor \u03b3) expression in HSCs. Celecoxib inhibited type I collagen mRNA and protein production in HSCs. Oral administration of celecoxib (20 mg\/kg\/day) significantly decreased hepatic collagen deposition and \u03b1-SMA (\u03b1-smooth muscle actin) expression in BDL- and TAA-treated rats. Celecoxib treatment significantly decreased mRNA expression of COX-2, \u03b1-SMA, transforming growth factor \u03b21 (TGF\u03b21) and collagen \u03b11(I) in both models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>Celecoxib shows a proapoptotic effect on HSCs through Akt inactivation and shows antifibrogenic effects in BDL- and TAA-treated rats, suggesting celecoxib as a novel antifibrotic agent of hepatic fibrosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/gut.2008.157420","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T03:58:49Z","timestamp":1233979129000},"page":"1517-1527","source":"Crossref","is-referenced-by-count":109,"title":["Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats"],"prefix":"10.1136","volume":"58","author":[{"given":"Y-H","family":"Paik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J K","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J I","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S H","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Y","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S H","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D K","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-H","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Y","family":"Chon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S I","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2009,2,6]]},"reference":[{"key":"2025090712143372000_58.11.1517.1","first-page":"156","article-title":"Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues.","volume":"330","author":"O\u2019Neill","year":"1993","journal-title":"FEBS Lett"},{"key":"2025090712143372000_58.11.1517.2","first-page":"G393","article-title":"Prostaglandin endoperoxide synthase: why two isoforms?","volume":"270","author":"Williams","year":"1996","journal-title":"Am J Physiol"},{"key":"2025090712143372000_58.11.1517.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108093450607"},{"key":"2025090712143372000_58.11.1517.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2003.07.001"},{"key":"2025090712143372000_58.11.1517.5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(00)80413-4","article-title":"New aspects of hepatic fibrosis.","volume":"32","author":"Brenner","year":"2000","journal-title":"J Hepatol"},{"key":"2025090712143372000_58.11.1517.6","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep0055"},{"key":"2025090712143372000_58.11.1517.7","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22761"},{"key":"2025090712143372000_58.11.1517.8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.36.23183"},{"key":"2025090712143372000_58.11.1517.9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.42.27300"},{"key":"2025090712143372000_58.11.1517.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)02301-X"},{"key":"2025090712143372000_58.11.1517.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.04.033"},{"key":"2025090712143372000_58.11.1517.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00904-1"},{"key":"2025090712143372000_58.11.1517.13","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-2753fje"},{"key":"2025090712143372000_58.11.1517.14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03009740310004766","article-title":"Selective cyclooxygenase-2 inhibitors: similarities and differences.","volume":"33","author":"Brune","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"2025090712143372000_58.11.1517.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12154-2"},{"key":"2025090712143372000_58.11.1517.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.25.12013"},{"key":"2025090712143372000_58.11.1517.17","first-page":"409","article-title":"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.","volume":"58","author":"Kawamori","year":"1998","journal-title":"Cancer Res"},{"key":"2025090712143372000_58.11.1517.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01202.x"},{"key":"2025090712143372000_58.11.1517.19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/labinvest.3780426","article-title":"Immortal activated human hepatic stellate cells generated by ectopic telomerase expression.","volume":"82","author":"Schnabl","year":"2002","journal-title":"Lab Invest"},{"key":"2025090712143372000_58.11.1517.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00178-8"},{"key":"2025090712143372000_58.11.1517.21","doi-asserted-by":"crossref","unstructured":"Paik YH Lee KS Lee HJ . Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid. Lab Invest 2006.","DOI":"10.1038\/labinvest.3700422"},{"key":"2025090712143372000_58.11.1517.22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270514"},{"key":"2025090712143372000_58.11.1517.23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.11.018"},{"key":"2025090712143372000_58.11.1517.24","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50182"},{"key":"2025090712143372000_58.11.1517.25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20665"},{"key":"2025090712143372000_58.11.1517.26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318212"},{"key":"2025090712143372000_58.11.1517.27","doi-asserted-by":"publisher","DOI":"10.1002\/art.10692"},{"key":"2025090712143372000_58.11.1517.28","first-page":"1306","article-title":"Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.","volume":"60","author":"Masferrer","year":"2000","journal-title":"Cancer Res"},{"key":"2025090712143372000_58.11.1517.29","first-page":"3178","article-title":"Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts.","volume":"7","author":"Blumenthal","year":"2001","journal-title":"Clin Cancer Res"},{"key":"2025090712143372000_58.11.1517.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67321-1"},{"key":"2025090712143372000_58.11.1517.31","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1044"},{"key":"2025090712143372000_58.11.1517.32","doi-asserted-by":"crossref","first-page":"G7","DOI":"10.1152\/ajpgi.2000.279.1.G7","article-title":"Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex.","volume":"279","author":"Eng","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2025090712143372000_58.11.1517.33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M009689200"},{"key":"2025090712143372000_58.11.1517.34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/jhep.2003.50380","article-title":"Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.","volume":"38","author":"Leng","year":"2003","journal-title":"Hepatology"},{"key":"2025090712143372000_58.11.1517.35","first-page":"6045","article-title":"Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.","volume":"60","author":"Williams","year":"2000","journal-title":"Cancer Res"},{"key":"2025090712143372000_58.11.1517.36","first-page":"2029","article-title":"Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.","volume":"62","author":"Waskewich","year":"2002","journal-title":"Cancer Res"},{"key":"2025090712143372000_58.11.1517.37","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701076"},{"key":"2025090712143372000_58.11.1517.38","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.302.1.18"},{"key":"2025090712143372000_58.11.1517.39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M006577200"},{"key":"2025090712143372000_58.11.1517.40","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0299fje"},{"key":"2025090712143372000_58.11.1517.41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.15.11397"},{"key":"2025090712143372000_58.11.1517.42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20143"},{"key":"2025090712143372000_58.11.1517.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)00945-6"},{"key":"2025090712143372000_58.11.1517.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80159-2"},{"key":"2025090712143372000_58.11.1517.45","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9041257"},{"key":"2025090712143372000_58.11.1517.46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.13.7614"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.2008.157420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:14:39Z","timestamp":1757272479000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.2008.157420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,6]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2009,10,15]]},"published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1136\/gut.2008.157420"],"URL":"https:\/\/doi.org\/10.1136\/gut.2008.157420","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,6]]}}}